Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001395064-19-000083

10% owner bought 2,000,000 shares at $2.50 ($5,000,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2019-10-08 Purchase +2,000,000 $2.50 $5,000,000 5,750,000 I: show line 1 in the form
Open-market purchases · 2,000,000 sh · avg $2.50 · $5,000,000
Loading xslF345X03/wf-form4_157442176475523.xml…